Discover our complete suite of visual function test systems
Preclinical
Celeris, our flagship preclinical system, revolutionizes rodent testing with dual function stimulator-electrodes. We also offer electroretinography (ERG) solutions for other small to large animals.
Clinical
We offer four broad categories of visual function tests—visual electrophysiology, visual psychophysical, objective acuity, and pupillometry, providing a complete picture of a person’s visual function.
Trial Services
Our trial services include study setup assistance, training, and data review. These trial services enable sites to gather consistent, quality data across multiple locations worldwide.
Supporting researchers and clinicians worldwide for more than forty years
Three reasons to partner with the premier manufacturer of visual electrophysiology systems
Expertise
We design all our hardware and software in-house to our and our customers’ exact specifications.
Technology
Our patented and trademarked platforms span the range from preclinical to clinical use, providing researchers and clinicians with products that have the broadest use and capability in the market.
Network
Our longstanding relationships within the electrophysiology community allow us to cross the bridge from academic labs into patient clinics, enabling easier collaboration between institutions.
Stay up to date with our latest news
-
MLMT and FST: Effective Endpoints in Gene Therapy Trials for Inherited Retinal Diseases
Featured image: Atsena Therapeutics co-founders Shannon Boye and Sanford Boye, and a non-human primate retina stained for adeno-associated virus-vectored protein is displayed on the screen. Courtesy of Atsena Therapeutics. Gene therapy development has accelerated in…
-
Visual electrophysiology shows biomarkers for neurodegenerative disease
With age, aspects of human biology and daily life compound, at times driving towards neurodegenerative disease that can cause memory loss, confusion, trouble walking, and personality changes. The current standard of care for neurodegenerative diseases…
-
Evaluating Traumatic Brain Injury with the Photopic Negative Response in Electroretinography
The CDC estimates there were nearly 69,000 deaths related to traumatic brain injury (TBI) in 2021 in the U.S. In response, there are, as of August 2024, over 200 clinical trials listed on clinicaltrials.gov that…
Meet us at our upcoming events
-
05Oct
-
18Oct
-
18Oct